Piclozotan
- Generic Name
- Piclozotan
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C23H24ClN3O2
- CAS Number
- 182415-09-4
- Unique Ingredient Identifier
- FQE44HS7AH
- Background
Piclozotan has been investigated for the treatment of Parkinson's Disease.
- Associated Conditions
- -
- Associated Therapies
- -
Preliminary Study of Piclozotan in Patients With Motor Complications Associated With Parkinson's Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2021-03-11
- Lead Sponsor
- Daiichi Sankyo
- Target Recruit Count
- 27
- Registration Number
- NCT00623363
- Locations
- 🇺🇸
Suny Downstate Medical Center, Brooklyn, New York, United States
🇺🇸UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
🇬🇹Hospital Multimedica, Guatemala, Guatemala
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath